ABVC vs CURI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

ABVC

56.5
AI Score
VS
ABVC Wins

CURI

41.0
AI Score

Investment Advisor Scores

ABVC

57score
Recommendation
HOLD

CURI

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABVC CURI Winner
Revenue 795,950 38.41M CURI
Net Income -5.14M 7.55M CURI
Net Margin -646.0% 19.7% CURI
Operating Income -4.95M 7.64M CURI
ROE -42.6% 18.2% CURI
ROA -24.2% 11.2% CURI
Total Assets 21.21M 67.47M CURI
Cash 192,068 5.38M CURI
Current Ratio 0.51 0.78 CURI

Relative Price Performance (Last 90 Days)

ABVC 1M: -27.0% · 3M: -26.3% CURI 1M: +20.9% · 3M: +11.4%

Current Technical Phase

ABVC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.5%), weak momentum, RSI 34

RSI (14): 34.4 · Price: $0.84

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $2.84

Fundamentals Snapshot

Metric ABVC CURI
Market Cap
Forward P/E 0.0 9.2
Trailing P/E
Revenue (TTM)
Revenue Growth 1.0% 0.2%
Gross Margin 1.0% 0.6%
Operating Margin 0.0% 0.4%
EPS -0.29 -0.01
Dividend Yield 0.11%

Frequently Asked Questions

Based on our detailed analysis, ABVC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.